Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00717691
Other study ID # 2008.003
Secondary ID
Status Completed
Phase N/A
First received July 15, 2008
Last updated April 27, 2012
Start date July 2008
Est. completion date December 2008

Study information

Verified date April 2012
Source Dynasplint Systems, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.


Description:

Determine the efficacy of dynamic splinting in treating patients with hallux limitus, in a randomized, controlled trial.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 2008
Est. primary completion date October 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Reduced flexibility in AROM of extension in the great toe

- Pain that is worsened by walking and/or squatting

- Impaired gait pattern

Exclusion Criteria:

- Metatarsal stress fracture

- Interdigital neuroma

- Sesamoid pathology

- Gout

- Metatarsalgia

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Metatarsophalangeal Extension Dynasplint System
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn for 30 minutes, three times per day, (while seated or resting in bed) totaling 1.5 hours per day.
Other:
Standard of Care
The current standard of care in treating Hallux Limitus will be given to all patients regardless of randomized categorization, and this includes: analgesic and nonsteroidal anti-inflammatory drugs (NSAIDs), orthotics with medial stiffness, and reduction of great toe movement in motions such as kneeling or squatting with the toes in an extended position.

Locations

Country Name City State
United States Atlanta Foot and Leg Clinic Jonesboro Georgia
United States Ankle and Foot Centers, PC Marietta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Dynasplint Systems, Inc.

Country where clinical trial is conducted

United States, 

References & Publications (12)

Becher C, Kilger R, Thermann H. Results of cheilectomy and additional microfracture techniques for the treatment of hallux rigidus. Foot Ankle Surg. 2005;(10): 155-160

Brodsky JW, Baum BS, Pollo FE, Mehta H. Prospective gait analysis in patients with first metatarsophalangeal joint arthrodesis for hallux rigidus. Foot Ankle Int. 2007 Feb;28(2):162-5. — View Citation

Canseco K, Long J, Marks R, Khazzam M, Harris G. Quantitative characterization of gait kinematics in patients with hallux rigidus using the Milwaukee foot model. J Orthop Res. 2008 Apr;26(4):419-27. — View Citation

DeFrino PF, Brodsky JW, Pollo FE, Crenshaw SJ, Beischer AD. First metatarsophalangeal arthrodesis: a clinical, pedobarographic and gait analysis study. Foot Ankle Int. 2002 Jun;23(6):496-502. — View Citation

Goucher NR, Coughlin MJ. Hallux metatarsophalangeal joint arthrodesis using dome-shaped reamers and dorsal plate fixation: a prospective study. Foot Ankle Int. 2006 Nov;27(11):869-76. — View Citation

Hockenbury RT. Forefoot problems in athletes. Med Sci Sports Exerc. 1999 Jul;31(7 Suppl):S448-58. Review. — View Citation

Kennedy JG, Chow FY, Dines J, Gardner M, Bohne WH. Outcomes after interposition arthroplasty for treatment of hallux rigidus. Clin Orthop Relat Res. 2006 Apr;445:210-5. — View Citation

Lau JT, Daniels TR. Outcomes following cheilectomy and interpositional arthroplasty in hallux rigidus. Foot Ankle Int. 2001 Jun;22(6):462-70. — View Citation

Payne C, Chuter V, Miller K. Sensitivity and specificity of the functional hallux limitus test to predict foot function. J Am Podiatr Med Assoc. 2002 May;92(5):269-71. — View Citation

Talarico LM, Vito GR, Goldstein L, Perler AD. Management of hallux limitus with distraction of the first metatarsophalangeal joint. J Am Podiatr Med Assoc. 2005 Mar-Apr;95(2):121-9. — View Citation

Willis B, John M. Dynamic Splinting Increases Flexion for Hallux Rigidus (Pilot Study). BioMechanics, 2007 Sept;14(9), pg49-53

Willis B. Dancers restore knee flexion through dynamic splinting. BioMechanics. 2008;Jan;15(1), pg49-54

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Active Range of Motion of Hallux (great toe) Extension Two Months No
Secondary Change in passive Range of Motion, Extension same No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05399472 - Teenage Functional Hallux Limitus and Ankle Dorsiflexion Study
Completed NCT03843177 - Association of Ingrown Toenails With Flat Foot, Hallux Abducto Valgus and Hallux Limitus
Completed NCT01048450 - Surgical Treatment for Hallux Rigidus N/A
Completed NCT04607863 - Foot Posture Index, Hallux Limitus in Patients With Chronic Low Back Pain. Gait With Optogait Sensor
Recruiting NCT05511532 - Foot Orthoses & Hallux Limitus in School-age Children N/A
Completed NCT01284985 - Short Term Follow-up of Patient Implanted With the Metatarso-Phalangeal Prosthesis METIS® N/A
Terminated NCT01589679 - Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial N/A